Minna Pauliina Mustikka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Minna Pauliina Mustikka has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Dan Gerard O'NEill
Pathobiology and Population Sciences, The Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield, Herts, AL9 7TA, UK.
2 shared publications Dave C. Brodbelt
Affiliation Pathobiology and Population Sciences, The Royal Veterinary College, Hatfield, Herts, United Kingdom
2 shared publicationsDavid B. Church
Affiliation Clinical Sciences and Services, The Royal Veterinary College, Hatfield, Herts, United Kingdom
2 shared publications- Elina M. Pietilä
Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland
2 shared publications - Thomas Grönthal
Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland
2 shared publications - Anna Kristina Mykkänen
Department of Equine and Small Animal Medicine, University of Helsinki, Helsinki, Finland
1 shared publication
Latest Publications
- Open Access
- 14 July 2026
- Published by SAGE Publications in Journal of Ocular Pharmacology and Therapeutics
- Vol. 42 (10) , 696-706
Vatinoxan Prevents Medetomidine-Associated Exophthalmos and Increased Glucose Concentrations in Blood and Aqueous Humor in Rats
Purpose: To evaluate whether vatinoxan, a peripherally selective alpha 2 -adrenoceptor antagonist, prevents the acute, medetomidine-associated ophthalmic changes in rats. Methods: Adult male Wistar rats ( n = 9 in each group) were randomly allocated to receive subcutaneous medetomidine 0.4 mg/kg and midazolam 2 mg/kg (MM), MM with vatinoxan 8 mg/kg (MM-V), or MM with regular insulin 1 IU/kg (MM-I). Macroscopic photography (to assess globe position) and slit-lamp biomicroscopy were performed, and blood glucose (BG) concentration, intraocular pressure (IOP), and central corneal thickness (CCT) were measured at intervals until 50 min post-treatment. Surgical anesthesia was then induced, and aqueous humor glucose (AHG) concentration was measured prior to euthanasia. Results: In MM and MM-I, exophthalmos worsened over time ( P < 0.05) and compared to MM-V ( P ≤ 0.04 for both). BG increased significantly over time ( P < 0.001) only in MM, and AHG was significantly higher in MM than in MM-V and MM-I ( P < 0.001). Lens clarity was decreased at 50 min in both MM ( P = 0.002) and MM-I ( P = 0.048), compared to MM-V. CCT was greater in MM-V than in MM at 50 min ( P = 0.02). Corneal clarity remained unchanged. IOP declined in all groups but remained significantly higher in MM-V 10 min versus 50 min post-treatment ( P = 0.02). Conclusions: Vatinoxan prevented pathological exophthalmos, lens opacification, the acute decline in IOP, hyperglycemia, and increased AHG in rats sedated with medetomidine–midazolam. Insulin similarly prevented hyperglycemia, but none of the ophthalmic changes. Acute alpha 2 -adrenoceptor agonist-mediated ophthalmic pathologies are independent from glycemic control.
- 14 July 2026
- Published by SAGE Publications in Journal of Ocular Pharmacology and Therapeutics
- Vol. 42 (10) , 696-706
Open AccessVatinoxan Prevents Medetomidine-Associated Exophthalmos and Increased Glucose Concentrations in Blood and Aqueous Humor in Rats
Purpose: To evaluate whether vatinoxan, a peripherally selective alpha 2 -adrenoceptor antagonist, prevents the acute, medetomidine-associated ophthalmic changes in rats. Methods: Adult male Wistar rats ( n = 9 in each group) were randomly allocated to receive subcutaneous medetomidine 0.4 mg/kg and midazolam 2 mg/kg (MM), MM with vatinoxan 8 mg/kg (MM-V), or MM with regular insulin 1 IU/kg (MM-I). Macroscopic photography (to assess globe position) and slit-lamp biomicroscopy were performed, and blood glucose (BG) concentration, intraocular pressure (IOP), and central corneal thickness (CCT) were measured at intervals until 50 min post-treatment. Surgical anesthesia was then induced, and aqueous humor glucose (AHG) concentration was measured prior to euthanasia. Results: In MM and MM-I, exophthalmos worsened over time ( P < 0.05) and compared to MM-V ( P ≤ 0.04 for both). BG increased significantly over time ( P < 0.001) only in MM, and AHG was significantly higher in MM than in MM-V and MM-I ( P < 0.001). Lens clarity was decreased at 50 min in both MM ( P = 0.002) and MM-I ( P = 0.048), compared to MM-V. CCT was greater in MM-V than in MM at 50 min ( P = 0.02). Corneal clarity remained unchanged. IOP declined in all groups but remained significantly higher in MM-V 10 min versus 50 min post-treatment ( P = 0.02). Conclusions: Vatinoxan prevented pathological exophthalmos, lens opacification, the acute decline in IOP, hyperglycemia, and increased AHG in rats sedated with medetomidine–midazolam. Insulin similarly prevented hyperglycemia, but none of the ophthalmic changes. Acute alpha 2 -adrenoceptor agonist-mediated ophthalmic pathologies are independent from glycemic control.
- Open Access
- 3 June 2026
- Published by Wiley in Veterinary Ophthalmology
- Vol. 29 (4) , e70206
The Early Ophthalmic Effects of Vatinoxan in Healthy Detomidine‐Sedated Horses
Objective: To evaluate the short‐term ophthalmic effects of vatinoxan, a peripherally selective alpha2‐adrenoceptor antagonist, in detomidine‐sedated horses. Animals Studied: Seven healthy horses without ophthalmic disease in a randomized, masked, two‐period crossover study design, with a ≥ 7‐day rest period. Procedures: After a bilateral palpebral block (lidocaine 40 mg) and baseline data collection, horses received intravenous detomidine (20 μg/kg [DET]) or DET with vatinoxan (200 μg/kg [DET‐VAT]). Intraocular pressure (IOP) was measured from the left eye while tear production (Schirmer tear test −1; STT) and vertical pupil diameter (VPD) were measured from the right eye at pre‐determined intervals until 25 min post‐treatment. Comparisons within and between treatments were analyzed with Student's t ‐tests (for IOP and VPD) or Wilcoxon's Rank Sum tests (for STT) followed by the Holm‐Bonferroni post hoc adjustment. Results: The overall post‐treatment IOP across time points was lower after DET (15.7 ± 1.9 [mean ± standard deviation] mmHg) than DET‐VAT (16.9 ± 2.0 mmHg) ( p = 0.01). IOP remained significantly ( p < 0.05) lower than baseline after DET for the whole 25 min observational period, while for DET‐VAT the corrected pairwise comparisons to baseline did not reach significance. The median (range) STT increased from baseline 17 (13–25) mm/min to 24 (18–35) mm/min ( p = 0.022) at 25 min after DET and from 18 (11–35) mm/min to 30 (18–35) mm/min ( p = 0.022) after DET‐VAT, respectively. VPD did not differ significantly from baseline after either treatment. Conclusions: Vatinoxan alleviated detomidine‐associated early decrease in IOP in healthy horses.
- 3 June 2026
- Published by Wiley in Veterinary Ophthalmology
- Vol. 29 (4) , e70206
Open AccessThe Early Ophthalmic Effects of Vatinoxan in Healthy Detomidine‐Sedated Horses
Objective: To evaluate the short‐term ophthalmic effects of vatinoxan, a peripherally selective alpha2‐adrenoceptor antagonist, in detomidine‐sedated horses. Animals Studied: Seven healthy horses without ophthalmic disease in a randomized, masked, two‐period crossover study design, with a ≥ 7‐day rest period. Procedures: After a bilateral palpebral block (lidocaine 40 mg) and baseline data collection, horses received intravenous detomidine (20 μg/kg [DET]) or DET with vatinoxan (200 μg/kg [DET‐VAT]). Intraocular pressure (IOP) was measured from the left eye while tear production (Schirmer tear test −1; STT) and vertical pupil diameter (VPD) were measured from the right eye at pre‐determined intervals until 25 min post‐treatment. Comparisons within and between treatments were analyzed with Student's t ‐tests (for IOP and VPD) or Wilcoxon's Rank Sum tests (for STT) followed by the Holm‐Bonferroni post hoc adjustment. Results: The overall post‐treatment IOP across time points was lower after DET (15.7 ± 1.9 [mean ± standard deviation] mmHg) than DET‐VAT (16.9 ± 2.0 mmHg) ( p = 0.01). IOP remained significantly ( p < 0.05) lower than baseline after DET for the whole 25 min observational period, while for DET‐VAT the corrected pairwise comparisons to baseline did not reach significance. The median (range) STT increased from baseline 17 (13–25) mm/min to 24 (18–35) mm/min ( p = 0.022) at 25 min after DET and from 18 (11–35) mm/min to 30 (18–35) mm/min ( p = 0.022) after DET‐VAT, respectively. VPD did not differ significantly from baseline after either treatment. Conclusions: Vatinoxan alleviated detomidine‐associated early decrease in IOP in healthy horses.
- Open Access
- 30 June 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (6) , e0326526
Conformational eyelid disorders in dogs under primary veterinary care in the UK - Epidemiology and clinical management
Introduction: Natural eyelid conformation is essential for normal function and health of the ocular surface. However, many modern dog types are deliberately bred for abnormal eyelid conformation associated with severe health and welfare issues. This study aimed to report the prevalence, demographic risk factors and clinical management under primary veterinary care for conformational eyelid disorders in dogs. Methods: The study explored the anonymised clinical records of all dogs under UK primary veterinary care within the VetCompass Programme during 2019. Risk factor analysis used multivariable logistic regression modelling. Results: From 2,250,417 dogs under primary veterinary care in 2019, the analysis included a random sample of 3,029 confirmed conformational eyelid disorder cases that included 2,752 (90.86%) entropion and 344 (11.36%) ectropion cases. After accounting for the subsampling process, the annual prevalence for overall conformational eyelid disorder in dogs was 0.36% (95% CI: 0.35–0.37). The annual prevalence for entropion in dogs overall was 0.33% (95% CI: 0.32–0.34). Breeds with highest annual prevalence for entropion were Shar-Pei (15.41%, 95% CI 14.00–16.91), Chow Chow (9.28%, 95% CI 7.64–11.14) and Neapolitan Mastiff (6.88%, 95% CI 3.02–13.14). The estimated annual prevalence for ectropion in dogs overall was 0.04% (95% CI: 0.04–0.05). Breeds with the highest annual prevalence for ectropion were Neapolitan Mastiff (4.30%, 95% CI 1.41–9.77), Saint Bernard (1.72%, 95% CI 0.86–3.05) and Basset Hound (1.59%, 95% CI 0.94–2.49). Surgical management was carried out for 414/2275 (18.20%) of the incident (2019) entropion cases and 12/305 (3.93%) of the incident (2019) ectropion cases. Conclusions: Normalisation of conformation-related health issues in certain high profile dog breeds have been discussed as a canine welfare priority for over half a century. The current results suggest that substantial work remains to be done to ensure good innate health for all dogs.
- 30 June 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (6) , e0326526
Open AccessConformational eyelid disorders in dogs under primary veterinary care in the UK - Epidemiology and clinical management
Introduction: Natural eyelid conformation is essential for normal function and health of the ocular surface. However, many modern dog types are deliberately bred for abnormal eyelid conformation associated with severe health and welfare issues. This study aimed to report the prevalence, demographic risk factors and clinical management under primary veterinary care for conformational eyelid disorders in dogs. Methods: The study explored the anonymised clinical records of all dogs under UK primary veterinary care within the VetCompass Programme during 2019. Risk factor analysis used multivariable logistic regression modelling. Results: From 2,250,417 dogs under primary veterinary care in 2019, the analysis included a random sample of 3,029 confirmed conformational eyelid disorder cases that included 2,752 (90.86%) entropion and 344 (11.36%) ectropion cases. After accounting for the subsampling process, the annual prevalence for overall conformational eyelid disorder in dogs was 0.36% (95% CI: 0.35–0.37). The annual prevalence for entropion in dogs overall was 0.33% (95% CI: 0.32–0.34). Breeds with highest annual prevalence for entropion were Shar-Pei (15.41%, 95% CI 14.00–16.91), Chow Chow (9.28%, 95% CI 7.64–11.14) and Neapolitan Mastiff (6.88%, 95% CI 3.02–13.14). The estimated annual prevalence for ectropion in dogs overall was 0.04% (95% CI: 0.04–0.05). Breeds with the highest annual prevalence for ectropion were Neapolitan Mastiff (4.30%, 95% CI 1.41–9.77), Saint Bernard (1.72%, 95% CI 0.86–3.05) and Basset Hound (1.59%, 95% CI 0.94–2.49). Surgical management was carried out for 414/2275 (18.20%) of the incident (2019) entropion cases and 12/305 (3.93%) of the incident (2019) ectropion cases. Conclusions: Normalisation of conformation-related health issues in certain high profile dog breeds have been discussed as a canine welfare priority for over half a century. The current results suggest that substantial work remains to be done to ensure good innate health for all dogs.
- Open Access
- 26 August 2024
- Published by Wiley in Equine Veterinary Journal
- Vol. 57 (3) , 598-610
Clinical features and outcomes of horses presenting with presumed equine immune mediated keratitis to two veterinary hospitals in the United Kingdom and Finland : 94 cases (2009–2021)
Background: There is limited literature regarding equine immune mediated keratitis (IMMK) in Europe. North America‐based publications describe minimal blepharospasm, rare corneal ulceration and no uveitis; clinical impression suggests these are seen in Europe. Objectives: Assess the prevalence of blepharospasm, corneal ulceration and uveitis and their impact on outcome in horses diagnosed with IMMK in Europe (UK and Finland). Study design: Retrospective case series. Methods: Clinical records of 94 horses with IMMK were evaluated. The UK and Finland populations were comparable; therefore, descriptive statistics were performed on combined data on subtypes of IMMK and clinical features. Odds ratios (OR) and confidence intervals (CI) were calculated for impact of blepharospasm, ulceration or presence of uveitis on the outcome of enucleation and treatment duration. Results: IMMK subtype was classified as 10/94 (10.6%) epithelial, 50/94 (53.2%) anterior stromal, 14/94 (14.9%) mid‐stromal, 4/94 (4.25%) endothelial and 16/94 (17.0%) unrecorded. After excluding three horses with incidental corneal ulceration, blepharospasm was documented in 34/91 (37.4%), corneal ulceration in 26/91 (28.6%), and signs of uveitis in 23/91 (25.3%) horses. Increased odds of enucleation were significantly associated with the presence of blepharospasm (OR 5.5, 95% CI 1.6–19.4, p = 0.008) and signs of uveitis (OR 8.9, 95% CI 2.6–30.8, p < 0.001), but not corneal ulceration. The presence of blepharospasm, corneal ulceration or uveitis did not significantly alter the odds of ongoing medication. Main limitations: Data were collected over a wide timeframe; the diagnosis was mainly made without histopathology; a broad definition of uveitis was used and there was a bias towards complicated cases being retained for follow‐up. Conclusions: The clinical features of IMMK were similar between two European countries but differed to USA descriptions. Blepharospasm, corneal ulceration and signs of uveitis can occur with IMMK; presence of blepharospasm and uveitis increase the odds of enucleation.
- 26 August 2024
- Published by Wiley in Equine Veterinary Journal
- Vol. 57 (3) , 598-610
Open AccessClinical features and outcomes of horses presenting with presumed equine immune mediated keratitis to two veterinary hospitals in the United Kingdom and Finland : 94 cases (2009–2021)
Background: There is limited literature regarding equine immune mediated keratitis (IMMK) in Europe. North America‐based publications describe minimal blepharospasm, rare corneal ulceration and no uveitis; clinical impression suggests these are seen in Europe. Objectives: Assess the prevalence of blepharospasm, corneal ulceration and uveitis and their impact on outcome in horses diagnosed with IMMK in Europe (UK and Finland). Study design: Retrospective case series. Methods: Clinical records of 94 horses with IMMK were evaluated. The UK and Finland populations were comparable; therefore, descriptive statistics were performed on combined data on subtypes of IMMK and clinical features. Odds ratios (OR) and confidence intervals (CI) were calculated for impact of blepharospasm, ulceration or presence of uveitis on the outcome of enucleation and treatment duration. Results: IMMK subtype was classified as 10/94 (10.6%) epithelial, 50/94 (53.2%) anterior stromal, 14/94 (14.9%) mid‐stromal, 4/94 (4.25%) endothelial and 16/94 (17.0%) unrecorded. After excluding three horses with incidental corneal ulceration, blepharospasm was documented in 34/91 (37.4%), corneal ulceration in 26/91 (28.6%), and signs of uveitis in 23/91 (25.3%) horses. Increased odds of enucleation were significantly associated with the presence of blepharospasm (OR 5.5, 95% CI 1.6–19.4, p = 0.008) and signs of uveitis (OR 8.9, 95% CI 2.6–30.8, p < 0.001), but not corneal ulceration. The presence of blepharospasm, corneal ulceration or uveitis did not significantly alter the odds of ongoing medication. Main limitations: Data were collected over a wide timeframe; the diagnosis was mainly made without histopathology; a broad definition of uveitis was used and there was a bias towards complicated cases being retained for follow‐up. Conclusions: The clinical features of IMMK were similar between two European countries but differed to USA descriptions. Blepharospasm, corneal ulceration and signs of uveitis can occur with IMMK; presence of blepharospasm and uveitis increase the odds of enucleation.
- Open Access
- 26 January 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (1) , e0260538
Breed and conformational predispositions for prolapsed nictitating membrane gland (PNMG) in dogs in the UK: A VetCompass study
Background: Prolapsed nictitating membrane gland (PNMG) is the most common disorder of the third eyelid in dogs. However, the epidemiology of PNMG in the wider dog population remains understudied.Methods: Using de-identified clinical data from the VetCompass Programme, this cohort study aimed to report the prevalence, demographic and breed-related risk factors of PNMG in dogs attending UK primary care veterinary practices in 2016.Results: There were 1,802 PNMG cases identified from 905,543 dogs, yielding an annual prevalence of 0.20% (95% confidence interval (CI) 0.19–0.21). The median age at first diagnosis was 0.63 years (IQR 0.33–1.98, range 0.11–18.00). Dogs aged under 1 year had 10.82 times the odds (95% CI 9.17–12.76) compared with dogs aged from 2 to under 4 years. Neutered animals had higher odds than entire animals within both sexes. Breeds with the highest odds of PNMG compared with crossbred dogs included Neapolitan Mastiff (odds ratio (OR) 34.26, 95%CI 15.92–73.75), English Bulldog (OR 24.08, 95% CI 20.62–28.13), Cane Corso (OR 14.66, 95% CI 8.18–26.28), Lhasa Apso (OR 12.37, 95% CI 10.26–14.92) and American Cocker Spaniel (OR 11.57, 95% CI 5.59–23.96). Purebred dogs had 1.43 times the odds (95% CI 1.26–1.63) of PNMG compared with crossbreed dogs. Breeds with brachycephalic skull conformation had 6.71 times the odds (95%CI 5.89–7.64) compared with breeds with mesocephalic skull conformation. Insured dogs had 1.89 times the odds (95% CI 1.65–2.16) compared with uninsured dogs.Conclusions: This study reports the largest cohort of primary-care PNMG cases assembled to date. The results showing young age at diagnosis along with the breed, purebred and brachycephalic skull conformation predispositions suggest a hereditary involvement in PNMG development. These results may help to guide breeding strategies to reduce the prevalence of PNMG and improve welfare in predisposed individuals.
- 26 January 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (1) , e0260538
Open AccessBreed and conformational predispositions for prolapsed nictitating membrane gland (PNMG) in dogs in the UK: A VetCompass study
Background: Prolapsed nictitating membrane gland (PNMG) is the most common disorder of the third eyelid in dogs. However, the epidemiology of PNMG in the wider dog population remains understudied.Methods: Using de-identified clinical data from the VetCompass Programme, this cohort study aimed to report the prevalence, demographic and breed-related risk factors of PNMG in dogs attending UK primary care veterinary practices in 2016.Results: There were 1,802 PNMG cases identified from 905,543 dogs, yielding an annual prevalence of 0.20% (95% confidence interval (CI) 0.19–0.21). The median age at first diagnosis was 0.63 years (IQR 0.33–1.98, range 0.11–18.00). Dogs aged under 1 year had 10.82 times the odds (95% CI 9.17–12.76) compared with dogs aged from 2 to under 4 years. Neutered animals had higher odds than entire animals within both sexes. Breeds with the highest odds of PNMG compared with crossbred dogs included Neapolitan Mastiff (odds ratio (OR) 34.26, 95%CI 15.92–73.75), English Bulldog (OR 24.08, 95% CI 20.62–28.13), Cane Corso (OR 14.66, 95% CI 8.18–26.28), Lhasa Apso (OR 12.37, 95% CI 10.26–14.92) and American Cocker Spaniel (OR 11.57, 95% CI 5.59–23.96). Purebred dogs had 1.43 times the odds (95% CI 1.26–1.63) of PNMG compared with crossbreed dogs. Breeds with brachycephalic skull conformation had 6.71 times the odds (95%CI 5.89–7.64) compared with breeds with mesocephalic skull conformation. Insured dogs had 1.89 times the odds (95% CI 1.65–2.16) compared with uninsured dogs.Conclusions: This study reports the largest cohort of primary-care PNMG cases assembled to date. The results showing young age at diagnosis along with the breed, purebred and brachycephalic skull conformation predispositions suggest a hereditary involvement in PNMG development. These results may help to guide breeding strategies to reduce the prevalence of PNMG and improve welfare in predisposed individuals.
- Open Access
- 4 September 2020
- Published by Wiley in Veterinary Ophthalmology
- Vol. 23 (5) , 892-898
Comparison of two rebound tonometers in healthy horses
Objective: To obtain a reference range for evaluation of intraocular pressure (IOP) in horses using Tonovet Plus®, to compare the IOP readings obtained with Tonovet®and Tonovet Plus®, and to evaluate the repeatability of readings.Animals studied and Procedures: Intraocular pressure of 30 client‐owned horses (60 eyes) with no signs of illness or ocular disease was evaluated using Tonovet®and Tonovet Plus®rebound tonometers. Horses’ mean age was 10.7 (range 6‐17) years. Triplicate measurements were performed without using sedatives or local anesthetics, with minimal restraint.Results: Calculated reference intervals (the CLSI robust method) were 14.4‐27.2 mmHg for Tonovet®and 16.0‐26.1 mmHg for Tonovet Plus®. Mean values (± standard deviation, SD [± coefficient of variation, CV]) obtained with Tonovet Plus®(21.6 ± 2.45 mmHg [11.3%]) were on average 0.6 mmHg higher than with Tonovet®(21.0 ± 3.14 mmHg [15.0%]), and a negligible statistical difference between the devices was found using the paired sample t test (P = .049). The correlation coefficient for the averaged triplicate measurements was 0.73. The average CV was 4.6% and 4.4% for Tonovet®and Tonovet Plus®, respectively.Conclusions: The repeatability of measurements was very good with both devices. The readings between the two devices differed statistically significantly, but the correlation was considered good and the variation was numerically small, and thus, the difference was considered clinically irrelevant. When monitoring disease process or treatment response in an individual patient, repeated readings are best performed using a similar device to avoid false interpretation of results.
- 4 September 2020
- Published by Wiley in Veterinary Ophthalmology
- Vol. 23 (5) , 892-898
Open AccessComparison of two rebound tonometers in healthy horses
Objective: To obtain a reference range for evaluation of intraocular pressure (IOP) in horses using Tonovet Plus®, to compare the IOP readings obtained with Tonovet®and Tonovet Plus®, and to evaluate the repeatability of readings.Animals studied and Procedures: Intraocular pressure of 30 client‐owned horses (60 eyes) with no signs of illness or ocular disease was evaluated using Tonovet®and Tonovet Plus®rebound tonometers. Horses’ mean age was 10.7 (range 6‐17) years. Triplicate measurements were performed without using sedatives or local anesthetics, with minimal restraint.Results: Calculated reference intervals (the CLSI robust method) were 14.4‐27.2 mmHg for Tonovet®and 16.0‐26.1 mmHg for Tonovet Plus®. Mean values (± standard deviation, SD [± coefficient of variation, CV]) obtained with Tonovet Plus®(21.6 ± 2.45 mmHg [11.3%]) were on average 0.6 mmHg higher than with Tonovet®(21.0 ± 3.14 mmHg [15.0%]), and a negligible statistical difference between the devices was found using the paired sample t test (P = .049). The correlation coefficient for the averaged triplicate measurements was 0.73. The average CV was 4.6% and 4.4% for Tonovet®and Tonovet Plus®, respectively.Conclusions: The repeatability of measurements was very good with both devices. The readings between the two devices differed statistically significantly, but the correlation was considered good and the variation was numerically small, and thus, the difference was considered clinically irrelevant. When monitoring disease process or treatment response in an individual patient, repeated readings are best performed using a similar device to avoid false interpretation of results.
- Open Access
- 31 July 2019
- Published by Wiley in Veterinary Ophthalmology
- Vol. 23 (1) , 148-159
Equine infectious keratitis in Finland: Associated microbial isolates and susceptibility profiles
Objective: To retrospectively describe laboratory findings, treatment, and outcome associated with equine infectious keratitis in Finland.Animals and procedures: Medical records of horses diagnosed with infectious keratitis in University of Helsinki Equine Hospital from January 2007 to June 2018 were reviewed.Results: Forty‐seven cases were included. Keratomycosis was diagnosed in 27 eyes and bacterial keratitis in 20 eyes.Aspergillus flavuswas the most frequent fungal isolate (9/17, 53%), followed byCylindrocarponsp. (3/17, 18%) andAspergillus fumigatus(2/17, 12%). Susceptibility was tested for 10/11Aspergillussp. isolates; all were susceptible to voriconazole while only two were susceptible to amphotericin B.Cylindrocarponsp. isolates were resistant to both agents.Streptococcus equisubsp.zooepidemicuswas the most frequent bacterial isolate (9/19, 47%), followed by other streptococci (4/19, 21%). All 13Streptococcussp. isolates were susceptible to penicillin, and all tested isolates (n = 11) were also susceptible to chloramphenicol. Mean duration of medical treatment was longer in fungal keratitis (38 days) than in bacterial keratitis (25 days) (P < .001). Twenty‐six of the eyes underwent globe‐sparing surgery in addition to medical therapy. Recovery was achieved in 66% (31/47) of all cases and in 59% (16/27) and 75% (15/20) (P = .264) of cases with keratomycosis and bacterial keratitis, respectively.Conclusions: AlthoughAspergillussp. andS zooepidemicuswere the most frequently encountered isolates, cytology, culture, and susceptibility testing are essential to differentiate bacterial and fungal keratitis and guide the clinician to choose the most efficient treatment.
- 31 July 2019
- Published by Wiley in Veterinary Ophthalmology
- Vol. 23 (1) , 148-159
Open AccessEquine infectious keratitis in Finland: Associated microbial isolates and susceptibility profiles
Objective: To retrospectively describe laboratory findings, treatment, and outcome associated with equine infectious keratitis in Finland.Animals and procedures: Medical records of horses diagnosed with infectious keratitis in University of Helsinki Equine Hospital from January 2007 to June 2018 were reviewed.Results: Forty‐seven cases were included. Keratomycosis was diagnosed in 27 eyes and bacterial keratitis in 20 eyes.Aspergillus flavuswas the most frequent fungal isolate (9/17, 53%), followed byCylindrocarponsp. (3/17, 18%) andAspergillus fumigatus(2/17, 12%). Susceptibility was tested for 10/11Aspergillussp. isolates; all were susceptible to voriconazole while only two were susceptible to amphotericin B.Cylindrocarponsp. isolates were resistant to both agents.Streptococcus equisubsp.zooepidemicuswas the most frequent bacterial isolate (9/19, 47%), followed by other streptococci (4/19, 21%). All 13Streptococcussp. isolates were susceptible to penicillin, and all tested isolates (n = 11) were also susceptible to chloramphenicol. Mean duration of medical treatment was longer in fungal keratitis (38 days) than in bacterial keratitis (25 days) (P < .001). Twenty‐six of the eyes underwent globe‐sparing surgery in addition to medical therapy. Recovery was achieved in 66% (31/47) of all cases and in 59% (16/27) and 75% (15/20) (P = .264) of cases with keratomycosis and bacterial keratitis, respectively.Conclusions: AlthoughAspergillussp. andS zooepidemicuswere the most frequently encountered isolates, cytology, culture, and susceptibility testing are essential to differentiate bacterial and fungal keratitis and guide the clinician to choose the most efficient treatment.